» Authors » Davide Rosati

Davide Rosati

Explore the profile of Davide Rosati including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 109
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salciccia S, Santarelli V, Di Pierro G, Del Giudice F, Bevilacqua G, Di Lascio G, et al.
Cancers (Basel) . 2024 Nov; 16(21). PMID: 39518044
: The advantage of a robotic-assisted (RARP) over a laparoscopic (LRP) approach in radical prostatectomy (RP) remains to be demonstrated. : The aim of the study is to use a...
2.
Santarelli V, Rosati D, Canale V, Salciccia S, Di Lascio G, Bevilacqua G, et al.
Life (Basel) . 2024 Jul; 14(7). PMID: 39063611
Contrast-enhanced ultrasound (CEUS) is an advanced imaging technique that integrates conventional US with the intravenous injection of specific US contrast agents (UCAs), combining the non-invasiveness of US with the higher...
3.
Rosati D, Mastino P, Romeo M, de Soccio G, Pentangelo D, Petrella C, et al.
Diseases . 2024 Jun; 12(6). PMID: 38920562
Recently, smell and taste disorders have seen renewed interest, as these symptoms are frequent complications of SARS-CoV-2 infection, since approximately 60% of patients affected by COVID-19 have shown olfactory and...
4.
Cerrato A, Aita S, Biancolillo A, Lagana A, Marini F, Montone C, et al.
Anal Chim Acta . 2024 May; 1307:342574. PMID: 38719419
Background: Metabolomics is nowadays considered one the most powerful analytical for the discovery of metabolic dysregulations associated with the insurgence of cancer, given the reprogramming of the cell metabolism to...
5.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, et al.
Asian J Urol . 2024 Apr; 11(2):191-207. PMID: 38680577
Objective: To analyze data available in the literature regarding a possible prognostic value of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in prostate cancer (PCa) patients stratified in non-metastatic...
6.
Tufano A, Rosati D, Moriconi M, Santarelli V, Canale V, Salciccia S, et al.
Curr Oncol . 2024 Feb; 31(2):818-827. PMID: 38392054
Background: Contrast-enhanced ultrasound (CEUS) is a diagnostic tool that is gaining popularity for its ability to improve overall diagnostic accuracy in bladder cancer (BC) staging. Our aim is to determine...
7.
Salciccia S, Frisenda M, Tufano A, Di Pierro G, Bevilacqua G, Rosati D, et al.
Clin Genitourin Cancer . 2023 Sep; 22(2):74-83. PMID: 37758559
Introduction: To analyze whether the use of an intermittent (IAD) versus continuous (CAD) androgen deprivation therapy for the treatment of biochemical progression after primary treatments in prostate cancer can influence...
8.
Mastino P, Rosati D, de Soccio G, Romeo M, Pentangelo D, Venarubea S, et al.
Antioxidants (Basel) . 2023 Jul; 12(7). PMID: 37507968
Introduction: OSAS is a disease that affects 2% of men and 4% of women of middle age. It is a major health public problem because untreated OSAS could lead to...
9.
Rosati D, Bononi M, Ruscito P, Radici M, Cavaliere C, Minni A
Indian J Otolaryngol Head Neck Surg . 2023 Feb; 74(Suppl 3):6206-6212. PMID: 36742527
The role of prophylactic central compartment neck dissection (CCND) in total thyroidectomy (TT) is controversial in patients without clinically evident lymph nodes metastasis (cN0) because of association with transient and...
10.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, et al.
Curr Oncol . 2022 Dec; 29(12):9474-9500. PMID: 36547159
Purpose: To prospectively evaluate the albumin/globulin ratio (AGR), neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) diagnostic and prognostic predictive value in a stratified population of prostate cancer (PC) cases. Methods:...